

Search
You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Pfizer."
12 result(s) displayed (1 - 12 of 40)
The EC-mandated divestment leaves the parent company with a 75% holding in the unit, which it plans to exit over time. Continue reading
Posted on May 3, 2013 8:58 AM
R.J. Kirk has quietly built a sterling record investing in and running some of the riskiest businesses around -- and he's done it from bucolic southwestern Virginia. Continue reading
Posted on June 24, 2011 1:11 PM
The pharmaceutical industry has seen a ton of deals over the past few years, some $230 billion in M&A activity from the top 10 pharmaceutical companies alone since the beginning of 2007. Continue reading
Posted on March 9, 2010 9:13 AM
The connection is so obvious we tend not to think about it too much. We should, though. Continue reading
Posted on December 11, 2009 12:00 PM
M&A activity may have stalled during the first half of the year, but deal lawyers still had plenty to talk about. Continue reading
Posted on August 7, 2009 10:56 AM
A conversation with former Pfizer, now University of California, San Francisco, biotech veteran Corey Goodman. Continue reading
Posted on August 7, 2009 10:36 AM
As Pfizer prepares for another digestive challenge in the form of Wyeth, it is trying to unload some compounds it already has. Continue reading
Posted on June 5, 2009 11:54 AM
How contingent value rights bridge gaps between buyers and sellers in the healthcare industry. Continue reading
Posted on May 19, 2009 3:00 PM
Abigail Barrow and Steven Shapin on the interaction of science, technology and economic development. Continue reading
Posted on May 15, 2009 11:59 AM
Skepticism abounds over Pfizer's ability to digest Wyeth. Continue reading
Posted on April 17, 2009 1:18 PM
Movable Type search results powered by Fast Search